An Early Rat Avoidance Study Reported THC–Alcohol Cross-Tolerance in Both Exposure Directions

A 1972 rat report found reduced alcohol effects after THC tolerance and reduced THC effects after alcohol tolerance. The result concerned a one-way avoidance task, rather than a universal reduction in combined-drug impairment.

The groups had different pretreatment histories

Rats trained in an avoidance situation were made tolerant to the behavioral depressant effects of THC or alcohol. Alcohol then depressed nontolerant animals more than THC-tolerant animals. Rats made alcohol-tolerant were also less affected by the THC challenge.

Two-way transfer did not establish complete equivalence

The abstract describes reduced effects in both directions without supplying a detailed matched potency comparison. It does not establish equal magnitude, complete protection or identical mechanisms. A shared behavioral endpoint can reflect convergence at several stages.

The task did not test contemporary human consumption

Injected animal challenges and a learned avoidance response differ from oral or inhaled use in people. The study also did not establish safety of simultaneous exposure. Cross-tolerance after a prior regimen and an acute drug interaction are different experimental questions.

This historical finding supports the existence of cross-drug adaptation under specified conditions. It does not show that cannabis users can safely drink more alcohol or that alcohol tolerance protects every cannabis-related function. Exposure direction, task and the degree of response reduction must remain explicit.

Related: interpreting cannabis tolerance claims.

Research cited

Newman LM; Lutz MP; Gould MH; Domino EF. 9 -Tetrahydrocannabinol and ethyl alcohol: evidence for cross-tolerance in the rat. Science (New York, N.Y.) (1972). doi:10.1126/science.175.4025.1022. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

A review published in 2020 graded psychiatric evidence from studies of CBD and CBD-containing nabiximols. Its recommendation labels should not be quoted as though every underlying intervention was purified CBD or every study was randomized. The included designs ranged widely The review identified 23 relevant studies spanning case reports, case…

Spread the love

Read Article: A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

A 2021 ocular CBD review brought together in-vitro and in-vivo research, proposed molecular targets and possible therapeutic applications. This evidence maps a development pathway; it does not establish that CBD products are effective eye treatments. The experimental system belongs in the conclusion A cellular result can identify a target or…

Spread the love

Read Article: CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

A 2021 review evaluated CBD research on reinforcing, motivational and withdrawal-related drug effects. These outcomes can inform substance-use-disorder research, but an improvement in one cannot establish successful treatment across all of them. The source combined preclinical and clinical reports The review covered alcohol, opioids, cannabinoids, nicotine and psychostimulants. An animal…

Spread the love

Read Article: CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us